Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
Abstract
Infections by the SARS-CoV-2 virus causing COVID-19 are presently a global emergency. The current vaccination effort may reduce the infection rate, but strain variants are emerging under selection pressure. Thus, there is an urgent need to find drugs that treat COVID-19 and save human lives. Hence, in this study, we identified phytoconstituents of an edible vegetable, Bitter melon (Momordica charantia), that affect the SARS-CoV-2 spike protein.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 27, 2021
- Source ID
- 10.1186/s13048-021-00872-3
Entities
People
- Rajesh Singh
- Santosh K. Singh
- Shailesh Singh
Organizations
- National Cancer Institute
- National Institutes of Health